Foslevodopa (CED0014122)

Record Information
Version1.0
Creation Date2026-04-14 20:59:55 UTC
Update Date2026-05-14 19:58:54 UTC
Accession NumberCHEM134085
Identification
Common NameFoslevodopa
ClassSmall Molecule
Description
Foslevodopa is an organic compound with the formula C9H12NO7P and an average molecular weight of 277.17 g/mol. Foslevodopa belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. It is categorized as a dopaminergic agent used in healthcare, pharmaceuticals, and veterinary products. The recorded route of exposure for this compound is subcutaneous.
Contaminant TypeNot Available
Chemical Structure
MOLSDFPDBSMILESInChI
SynonymsNot Available
Chemical FormulaC9H12NO7P
Average Molecular Mass277.169 g/mol
Monoisotopic Mass277.035 g/mol
CAS Registry Number97321-87-4
IUPAC NameNot Available
Traditional NameNot Available
SMILESN[C@@H](CC1=CC=C(OP(O)(O)=O)C(O)=C1)C(O)=O
InChI IdentifierInChI=1S/C9H12NO7P/c10-6(9(12)13)3-5-1-2-8(7(11)4-5)17-18(14,15)16/h1-2,4,6,11H,3,10H2,(H,12,13)(H2,14,15,16)/t6-/m0/s1
InChI KeyYNDMEEULGSTYJT-LURJTMIESA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
5743.0Log mg/kg[3200:10000]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
373Dopaminergic agentsHealthcare, pharmaceuticals & veterinary productsNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureTyrosine 3-monooxygenaseP04177Rattus norvegicusPredicted (SEA)0.0778492
Click to view 3D structureSHC-transforming protein 2P98077HumansPredicted (SEA)0.155698
Click to view 3D structureSolute carrier organic anion transporter family member 1C1Q9ERB5Mus musculusPredicted (SEA)0.233548
Click to view 3D structureGlutamate racemaseQ03469Lactobacillus fermentumPredicted (SEA)1.47914
Peroxisome proliferator-activated receptor gamma structureClick to view 3D structurePeroxisome proliferator-activated receptor gammaP37231HumansPredicted (SEA)39.0803
Click to view 3D structurePhosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2Q6P549Mus musculusPredicted (SEA)0.155698
Type II inositol 1,4,5-trisphosphate 5-phosphatase structureClick to view 3D structureType II inositol 1,4,5-trisphosphate 5-phosphataseP32019HumansPredicted (SEA)0.155698
Tyrosine-protein kinase Fyn structureClick to view 3D structureTyrosine-protein kinase FynP06241HumansPredicted (SEA)219.301
Tyrosine-protein kinase Lck structureClick to view 3D structureTyrosine-protein kinase LckP06239HumansPredicted (SEA)347.052
Click to view 3D structureMetabotropic glutamate receptor 4P31423Rattus norvegicusPredicted (SEA)6.61718
Click to view 3D structureAromatic-L-amino-acid decarboxylaseO88533Mus musculusPredicted (SEA)0.155698
Transthyretin structureClick to view 3D structureTransthyretinP02766HumansPredicted (SEA)9.18621
Click to view 3D structureMetabotropic glutamate receptor 6P35349Rattus norvegicusPredicted (SEA)2.64687
Click to view 3D structurePolyunsaturated fatty acid lipoxygenase ALOX15P12530Oryctolagus cuniculusPredicted (SEA)4.12601
Metabotropic glutamate receptor 4 structureClick to view 3D structureMetabotropic glutamate receptor 4Q14833HumansPredicted (SEA)17.7496
Epidermal growth factor receptor structureClick to view 3D structureEpidermal growth factor receptorP00533HumansPredicted (SEA)646.538
Aminopeptidase N structureClick to view 3D structureAminopeptidase NP15144HumansPredicted (SEA)90.3051
Click to view 3D structureCytosol aminopeptidaseP28839Sus scrofaPredicted (SEA)6.53933
Click to view 3D structureAminopeptidase NP15145Sus scrofaPredicted (SEA)51.0691
Endoplasmic reticulum aminopeptidase 2 structureClick to view 3D structureEndoplasmic reticulum aminopeptidase 2Q6P179HumansPredicted (SEA)53.0153
Click to view 3D structureMetabotropic glutamate receptor 8P70579Rattus norvegicusPredicted (SEA)5.52729
Click to view 3D structureKynureninaseP70712Rattus norvegicusPredicted (SEA)2.02408
Click to view 3D structureMetabotropic glutamate receptor 6O15303HumansPredicted (SEA)5.83869
Glutamate receptor 2 structureClick to view 3D structureGlutamate receptor 2P42262HumansPredicted (SEA)2.88042
Click to view 3D structureGlutamate receptor 2P19491Rattus norvegicusPredicted (SEA)1.40129
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available